Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 21, 2024 1:10 PM 1 min read

Salesforce Cuts Wait Times In Healthcare, New Collaboration Transforms Prior Authorizations

by Lekha Gupta Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Salesforce, Inc. (NYSE:CRM) collaborated with Blue Shield of California to provide physicians and patients with nearly instant prior authorization answers, eliminating the typical days-long wait.

The new platform will integrate with Care Connect, Blue Shield’s care management system, establishing a clinical infrastructure that emphasizes ongoing preventive care and wellness rather than just responding to medical needs.

In the future, prior authorization requests will automatically notify the health plan’s nurses, social workers, and behavioral health specialists when a member may require new or enhanced health support.

The nonprofit health plan’s prior authorization platform, developed on Salesforce Health Cloud, will integrate with physician systems to collect essential clinical data from electronic health records and streamline over 20 disparate systems.

This will enable members and physicians to receive prior authorization in nearly real-time.

The testing will start in early 2025, with a limited rollout later that year. Full real-time authorization capabilities are expected by January 2026, followed by additional features.

Jeff Amann, executive vice president and general manager, Salesforce Industries said, “With Blue Shield of California, we’re rebuilding the prior authorization process with new innovations that support near real-time decision-making so providers can more quickly, transparently and compliantly deliver the attentive care their patients deserve.”

Investors can gain exposure to the stock via iShares Expanded Tech-Software Sector ETF (BATS:IGV) and First Trust DJ Internet Index Fund (NYSE:FDN).

Price Action: CRM shares are down 0.51% at $291.44 at the last check Monday.

Image via Shutterstock

Read Next:

  • Microsoft, Salesforce Battle Heats Up As AI Agent Technology Takes Center Stage

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EquitiesLarge CapNewsContractsAI GeneratedBriefsStories That Matter
CRM Logo
CRMSalesforce Inc
$191.550.10%
Overview
FDN Logo
FDNFirst Trust DJ Internet Index Fund
$245.60-%
IGV Logo
IGViShares Expanded Tech-Software Sector ETF
$82.740.34%
CRM Logo
CRMSalesforce Inc
$191.550.10%
Overview
FDN Logo
FDNFirst Trust DJ Internet Index Fund
$245.60-%
IGV Logo
IGViShares Expanded Tech-Software Sector ETF
$82.740.34%
Comments
Loading...